Helen Krontiras

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Laura J. Esserman, Donald A. Berry, Angela DeMichele et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text

Medicine, Biostatistics, Oncology +11

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Laura J. Esserman, Donald A. Berry, Maggie C.U. Cheang et al. · Breast Cancer Research and Treatment · 2011 · 376 citations · Full text

Medicine, Biostatistics, Oncology +17

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

X. Cynthia, Feng Gao, Jingqin Luo et al. · Clinical Cancer Research · 2017 · 376 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors

Cheryl L. Rock, Shirley W. Flatt, Tim Byers et al. · Journal of Clinical Oncology · 2015 · 219 citations

Public Health, Health Behavior, Health Promotion +17

Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer

Ashka Y. Pandya, Lynya Talley, Andra R. Frost et al. · Clinical Cancer Research · 2004 · 208 citations

Medicine, Molecular Biology, Oncology +17